NZ277529A - Enantioselective preparation of chiral triaryl (where aryl is either carbocyclic or heterocyclic) derivatives, chiral intermediates - Google Patents
Enantioselective preparation of chiral triaryl (where aryl is either carbocyclic or heterocyclic) derivatives, chiral intermediatesInfo
- Publication number
- NZ277529A NZ277529A NZ277529A NZ27752994A NZ277529A NZ 277529 A NZ277529 A NZ 277529A NZ 277529 A NZ277529 A NZ 277529A NZ 27752994 A NZ27752994 A NZ 27752994A NZ 277529 A NZ277529 A NZ 277529A
- Authority
- NZ
- New Zealand
- Prior art keywords
- formula
- compound
- pyridyl
- group
- methoxyphenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939326173A GB9326173D0 (en) | 1993-12-22 | 1993-12-22 | Chemical compounds and process |
PCT/GB1994/002799 WO1995017386A1 (en) | 1993-12-22 | 1994-12-22 | An enantioselective process for the preparation of chiral triaryl derivatives and chiral intermediates for use therein |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ277529A true NZ277529A (en) | 1998-03-25 |
Family
ID=10747020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ277529A NZ277529A (en) | 1993-12-22 | 1994-12-22 | Enantioselective preparation of chiral triaryl (where aryl is either carbocyclic or heterocyclic) derivatives, chiral intermediates |
Country Status (12)
Country | Link |
---|---|
US (1) | US5608070A (sv) |
EP (1) | EP0736010A1 (sv) |
JP (1) | JPH09510691A (sv) |
KR (1) | KR100328191B1 (sv) |
AU (1) | AU689837B2 (sv) |
CA (1) | CA2177817A1 (sv) |
CZ (1) | CZ294296B6 (sv) |
FI (1) | FI962599A (sv) |
GB (2) | GB9326173D0 (sv) |
HU (1) | HUT76284A (sv) |
NZ (1) | NZ277529A (sv) |
WO (1) | WO1995017386A1 (sv) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9212673D0 (en) * | 1992-06-15 | 1992-07-29 | Celltech Ltd | Chemical compounds |
GB9222253D0 (en) * | 1992-10-23 | 1992-12-09 | Celltech Ltd | Chemical compounds |
GB9304919D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
GB9304920D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
JP3806144B2 (ja) * | 1993-12-22 | 2006-08-09 | セルテック セラピューティックス リミテッド | 三置換フェニル誘導体、その調製方法とホスホジエステラーゼ(iv型)阻害剤としてのその使用 |
GB9326600D0 (en) * | 1993-12-22 | 1994-03-02 | Celltech Ltd | Chemical compounds |
US5786354A (en) * | 1994-06-21 | 1998-07-28 | Celltech Therapeutics, Limited | Tri-substituted phenyl derivatives and processes for their preparation |
US6245774B1 (en) | 1994-06-21 | 2001-06-12 | Celltech Therapeutics Limited | Tri-substituted phenyl or pyridine derivatives |
GB9412573D0 (en) * | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
GB9412571D0 (en) | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
GB9412672D0 (en) * | 1994-06-23 | 1994-08-10 | Celltech Ltd | Chemical compounds |
GB9523675D0 (en) * | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
US5710170A (en) * | 1995-12-15 | 1998-01-20 | Merck Frosst Canada, Inc. | Tri-aryl ethane derivatives as PDE IV inhibitors |
EP0873311A1 (en) * | 1995-12-15 | 1998-10-28 | Merck Frosst Canada Inc. | Tri-aryl ethane derivatives as pde iv inhibitors |
GB9603723D0 (en) * | 1996-02-22 | 1996-04-24 | Merck & Co Inc | Diphenyl pyridyl derivatives as pde iv inhibitors |
GB9526243D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
GB9526246D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
GB9526245D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
AR006550A1 (es) * | 1996-04-17 | 1999-09-08 | Merck & Co Inc | Metodo de preparacion de inhibidores de fosfodiesterasa iv |
GB9608435D0 (en) * | 1996-04-24 | 1996-06-26 | Celltech Therapeutics Ltd | Chemical compounds |
US5808082A (en) * | 1996-05-08 | 1998-09-15 | Merck & Co., Inc. | Method of preparing phosphodiesterase IV inhibitors |
ATE197148T1 (de) * | 1996-05-08 | 2000-11-15 | Merck & Co Inc | Verfahren zur herstellung von phosphodiesterase iv inhibitoren |
GB9619284D0 (en) * | 1996-09-16 | 1996-10-30 | Celltech Therapeutics Ltd | Chemical compounds |
TW508353B (en) * | 1996-09-17 | 2002-11-01 | Merck & Co Inc | Method of preparing phosphodiesterase IV inhibitors |
WO1998012178A1 (en) * | 1996-09-17 | 1998-03-26 | Merck & Co., Inc. | Method of preparing phosphodiesterase iv inhibitors |
WO1998012340A1 (en) * | 1996-09-17 | 1998-03-26 | Merck & Co., Inc. | Process for bioreduction of bisaryl ketone to bisaryl alcohol |
US5900368A (en) * | 1996-09-17 | 1999-05-04 | Merck & Co., Inc. | Process for bioreduction of bisaryl ketone to bisaryl alcohol |
GB9622363D0 (en) * | 1996-10-28 | 1997-01-08 | Celltech Therapeutics Ltd | Chemical compounds |
GB9625184D0 (en) * | 1996-12-04 | 1997-01-22 | Celltech Therapeutics Ltd | Chemical compounds |
US6057329A (en) * | 1996-12-23 | 2000-05-02 | Celltech Therapeutics Limited | Fused polycyclic 2-aminopyrimidine derivatives |
GB9705361D0 (en) * | 1997-03-14 | 1997-04-30 | Celltech Therapeutics Ltd | Chemical compounds |
GB9713087D0 (en) * | 1997-06-20 | 1997-08-27 | Celltech Therapeutics Ltd | Chemical compounds |
CA2321307A1 (en) | 1998-02-27 | 1999-09-02 | Venkatachala L. Narayanan | Disubstituted lavendustin a analogs and pharmaceutical compositions comprising the analogs |
US6316434B1 (en) | 1999-03-03 | 2001-11-13 | Merck Frosst Canada & Co. | Assay for emetic activity |
US6200993B1 (en) * | 1999-05-05 | 2001-03-13 | Merck Frosst Canada & Co. | Heterosubstituted pyridine derivatives as PDE4 inhibitors |
US6316472B1 (en) * | 1999-05-13 | 2001-11-13 | Merck Frosst Canada & Co. | Heterosubstituted pyridine derivatives as PDE 4 inhibitors |
GB9914258D0 (en) | 1999-06-18 | 1999-08-18 | Celltech Therapeutics Ltd | Chemical compounds |
AU775373B2 (en) | 1999-10-01 | 2004-07-29 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
GB9924862D0 (en) | 1999-10-20 | 1999-12-22 | Celltech Therapeutics Ltd | Chemical compounds |
US6410563B1 (en) | 1999-12-22 | 2002-06-25 | Merck Frosst Canada & Co. | Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
MY123585A (en) | 2000-03-23 | 2006-05-31 | Merck Canada Inc | Tri-aryl-substituted-ethane pde4 inhibitors. |
US6639077B2 (en) | 2000-03-23 | 2003-10-28 | Merck Frosst Canada & Co. | Tri-aryl-substituted-ethane PDE4 inhibitors |
AU2001261962B2 (en) | 2000-05-25 | 2005-04-21 | Merck Frosst Canada Ltd | Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor |
US6740666B2 (en) | 2000-12-20 | 2004-05-25 | Merck & Co., Inc. | Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
EP1397359B1 (en) | 2001-05-24 | 2005-08-31 | Merck Frosst Canada & Co. | 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors |
AU2002312933B2 (en) * | 2001-05-29 | 2007-12-06 | Schering Ag | CDK inhibiting pyrimidines, production thereof and their use as medicaments |
JO2311B1 (en) | 2001-08-29 | 2005-09-12 | ميرك فروست كندا ليمتد | Alkyl inhibitors Ariel phosphodiesterase-4 |
US7262196B2 (en) * | 2003-02-11 | 2007-08-28 | Prosidion Limited | Tri(cyclo) substituted amide glucokinase activator compounds |
US7678363B2 (en) | 2005-08-26 | 2010-03-16 | Braincells Inc | Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs |
EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
EP1940389A2 (en) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
EP2021000A2 (en) | 2006-05-09 | 2009-02-11 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
MX2008014320A (es) | 2006-05-09 | 2009-03-25 | Braincells Inc | Neurogenesis mediada por el receptor de 5-hidroxitriptamina. |
EP2068872A1 (en) | 2006-09-08 | 2009-06-17 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
EP2804603A1 (en) | 2012-01-10 | 2014-11-26 | President and Fellows of Harvard College | Beta-cell replication promoting compounds and methods of their use |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2257272B1 (sv) * | 1974-01-15 | 1978-08-25 | Pharmascience Labo | |
US4193926A (en) * | 1974-03-20 | 1980-03-18 | Schering Aktiengesellschaft | 4-(Polyalkoxy phenyl)-2-pyrrolidones |
DE2413935A1 (de) * | 1974-03-20 | 1975-10-16 | Schering Ag | 4-(polyalkoxy-phenyl)-2-pyrrolidone |
DE2541855A1 (de) * | 1975-09-18 | 1977-03-31 | Schering Ag | 4-(polyalkoxy-phenyl)-2-pyrrolidone ii |
SU888821A3 (ru) * | 1976-12-03 | 1981-12-07 | Шеринг Аг (Инофирма) | Способ получени 5-(замещенный фенил)-оксазолидинонов или их серусодержащих аналогов |
ATE798T1 (de) * | 1978-06-15 | 1982-04-15 | Imperial Chemical Industries Plc | Entzuendungshemmende 1-phe nyl-2-aminoaethanol-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen zur oertlichen anwendung. |
US5128358A (en) * | 1988-01-19 | 1992-07-07 | Pfizer Inc. | Aryl substituted nitrogen heterocyclic antidepressants |
HU215433B (hu) * | 1986-04-29 | 2000-05-28 | Pfizer Inc. | Eljárás új 2-oxo-5-fenil-pirimidin-származékok előállítására |
US4921862A (en) * | 1986-05-29 | 1990-05-01 | Syntex (U.S.A.) Inc. | Carbostyril derivatives as combined thromboxane synthetase and cyclic-amp phosphodiesterase inhibitors |
US4792561A (en) * | 1986-05-29 | 1988-12-20 | Syntex (U.S.A.) Inc. | Carbostyril derivatives as combined thromboxane synthetase and cyclic-AMP phosphodiesterase inhibitors |
US4971959A (en) * | 1987-04-14 | 1990-11-20 | Warner-Lambert Company | Trisubstituted phenyl analogs having activity for congestive heart failure |
US5274002A (en) * | 1987-04-14 | 1993-12-28 | Warner-Lambert Company | Trisubstituted phenyl analogs having activity for congestive heart failure |
EP0469013B1 (de) * | 1989-04-17 | 1995-06-28 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Neue arylpyridazine, ihre herstellung, verwendung und sie enthaltende arzneimittel |
DE4003919A1 (de) * | 1990-02-09 | 1991-08-14 | Basf Ag | Heteroarylalkene, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung |
GB9007762D0 (en) * | 1990-04-05 | 1990-06-06 | Beecham Group Plc | Novel compounds |
AU7854291A (en) * | 1990-04-27 | 1991-11-27 | Rorer International (Holdings), Inc. | Styryl compounds which inhibit egf receptor protein tyrosine kinase |
US5393788A (en) * | 1990-07-10 | 1995-02-28 | Smithkline Beecham Corporation | Phenylalkyl oxamides |
US5124455A (en) * | 1990-08-08 | 1992-06-23 | American Home Products Corporation | Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents |
EP0550576A1 (en) * | 1990-09-28 | 1993-07-14 | Smith Kline & French Laboratories Limited | Phenylpyridinol derivatives as medicaments |
WO1992006963A1 (de) * | 1990-10-16 | 1992-04-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Arylpyridazinone |
AU9030691A (en) * | 1990-11-06 | 1992-05-26 | Smithkline Beecham Corporation | Imidazolidinone compounds |
GB9027055D0 (en) * | 1990-12-13 | 1991-02-06 | Sandoz Ltd | Organic compounds |
IE71647B1 (en) * | 1991-01-28 | 1997-02-26 | Rhone Poulenc Rorer Ltd | Benzamide derivatives |
EP0581805A1 (de) * | 1991-04-26 | 1994-02-09 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Neue pyridazine |
US5191084A (en) * | 1991-05-01 | 1993-03-02 | American Home Products Corporation | Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents |
PT100441A (pt) * | 1991-05-02 | 1993-09-30 | Smithkline Beecham Corp | Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso |
EP0540165A1 (en) * | 1991-10-03 | 1993-05-05 | Zeneca Limited | Alkanoic acid derivatives |
CA2080554A1 (en) * | 1991-10-15 | 1993-04-16 | Mitsubishi Chemical Corporation | Styrene derivatives |
US5326898A (en) * | 1992-02-11 | 1994-07-05 | Allergan, Inc. | Substituted phenylethenyl compounds having retinoid-like biological activity |
EP0633775B1 (en) * | 1992-04-02 | 2000-05-31 | Smithkline Beecham Corporation | Compounds useful for treating inflammatory diseases and for inhibiting production of tumor necrosis factor |
PL307265A1 (en) * | 1992-07-28 | 1995-05-15 | Rhone Poulenc Rorer Ltd | Compounds containing a phenyl group bonded with aryl or heteroaryl group through their bonding aliphatic group or that containing heteroatom |
DK0672031T3 (da) * | 1992-12-02 | 2003-06-10 | Pfizer | Catecholdiethere som selektive PDE IV-inhibitorer |
TW263495B (sv) * | 1992-12-23 | 1995-11-21 | Celltech Ltd |
-
1993
- 1993-12-22 GB GB939326173A patent/GB9326173D0/en active Pending
-
1994
- 1994-12-21 US US08/361,439 patent/US5608070A/en not_active Expired - Lifetime
- 1994-12-22 CZ CZ19961819A patent/CZ294296B6/cs not_active IP Right Cessation
- 1994-12-22 WO PCT/GB1994/002799 patent/WO1995017386A1/en active IP Right Grant
- 1994-12-22 EP EP95903885A patent/EP0736010A1/en not_active Withdrawn
- 1994-12-22 KR KR1019960703333A patent/KR100328191B1/ko not_active IP Right Cessation
- 1994-12-22 AU AU12783/95A patent/AU689837B2/en not_active Ceased
- 1994-12-22 GB GB9612213A patent/GB2299082B/en not_active Expired - Lifetime
- 1994-12-22 NZ NZ277529A patent/NZ277529A/en not_active IP Right Cessation
- 1994-12-22 HU HU9601725A patent/HUT76284A/hu unknown
- 1994-12-22 CA CA002177817A patent/CA2177817A1/en not_active Abandoned
- 1994-12-22 JP JP7517279A patent/JPH09510691A/ja active Pending
-
1996
- 1996-06-20 FI FI962599A patent/FI962599A/sv not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GB9326173D0 (en) | 1994-02-23 |
CA2177817A1 (en) | 1995-06-29 |
FI962599A0 (sv) | 1996-06-20 |
US5608070A (en) | 1997-03-04 |
GB9612213D0 (en) | 1996-08-14 |
EP0736010A1 (en) | 1996-10-09 |
JPH09510691A (ja) | 1997-10-28 |
AU1278395A (en) | 1995-07-10 |
CZ181996A3 (en) | 1997-02-12 |
AU689837B2 (en) | 1998-04-09 |
GB2299082B (en) | 1998-06-17 |
WO1995017386A1 (en) | 1995-06-29 |
HU9601725D0 (en) | 1996-08-28 |
GB2299082A (en) | 1996-09-25 |
KR100328191B1 (ko) | 2002-07-27 |
CZ294296B6 (cs) | 2004-11-10 |
FI962599A (sv) | 1996-06-20 |
HUT76284A (en) | 1997-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ277529A (en) | Enantioselective preparation of chiral triaryl (where aryl is either carbocyclic or heterocyclic) derivatives, chiral intermediates | |
US6077854A (en) | Tri-substituted phenyl derivatives and processes for their preparation | |
US6245774B1 (en) | Tri-substituted phenyl or pyridine derivatives | |
US5866593A (en) | Trisubstituted phenyl derivatives and processes for their preparation | |
US6297264B1 (en) | Trisubstituted phenyl derivatives and process for their preparation | |
US5859034A (en) | Tri-substituted phenyl compounds which have useful pharmaceutical activity | |
US5780478A (en) | Tetra-substituted phenyl derivatives | |
US5622977A (en) | Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same | |
US5776958A (en) | Trisubstituted phenyl derivatives and processes for their preparation | |
US5798373A (en) | Tri-substituted phenyl derivatives useful as PDE IV inhibitors | |
US5633257A (en) | Cyclo(alkyl and alkenyl)phenyl-alkenylyl(aryl and heteroaryl)compounds and pharmaceutical compositions containing them | |
US5693659A (en) | Substituted oxime derivatives and processes for their preparation | |
KR100501865B1 (ko) | 포스포디에스테라제iv억제제로서유용한삼치환된페닐유도체 | |
CA2192643C (en) | Tri-substituted phenyl derivatives useful as pde iv inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RENW | Renewal (renewal fees accepted) | ||
RENW | Renewal (renewal fees accepted) | ||
RENW | Renewal (renewal fees accepted) | ||
EXPY | Patent expired |